Tirosint Cost in Arizona 2026: Cash Price, Insurance, Medicaid and Compounding Options

What Is Tirosint and Why Does It Cost More Than Generic Levothyroxine?

Tirosint is a proprietary formulation of levothyroxine sodium that comes in a soft gelatin capsule or liquid form containing very few excipients: glycerin, gelatin, and water. Standard levothyroxine tablets contain fillers such as acacia, lactose, talc, and dyes that can interfere with absorption in patients with celiac disease, lactose intolerance, or other gastrointestinal conditions. That pharmacokinetic difference is what clinicians use to justify the higher price.

Generic levothyroxine tablets are available at most Arizona pharmacies for $4 to $10 per month. Tirosint's list price sits near $230 per month, a gap that matters enormously for uninsured or underinsured Arizonans. The formulation difference is not cosmetic. Vita et al. (2014, N=45) demonstrated that patients switched from tablet levothyroxine to the liquid formulation showed statistically significant improvement in TSH normalization, particularly those with Helicobacter pylori infection or gastric atrophy [1]. The FDA approved the Tirosint gel capsule under NDA 021924; the current prescribing information specifies it for hypothyroidism of any etiology requiring replacement or suppressive therapy [2].

Thyroid disease is common. The CDC estimates that approximately 4.6% of the U.S. population age 12 and older has hypothyroidism, translating to roughly 400,000 affected adults in Arizona [3]. Most are managed adequately on generic tablets, but a clinically meaningful subset absorbs levothyroxine poorly and may benefit from an alcohol-free liquid or gelatin-capsule formulation.

Tirosint Cash Price in Arizona in 2026

At Arizona retail pharmacies, the cash price for a 30-day supply of Tirosint gel capsules is approximately $230 in 2026. Prices vary by dose strength and pharmacy. GoodRx and similar coupon platforms sometimes reduce this to $180 to $210 at select chains, though savings vary by location and specific strength.

That $230 figure comes from the IBSA manufacturer wholesale average cost and is consistent across major Arizona chains including CVS, Walgreens, Fry's Pharmacy, and Safeway. Independent pharmacies may price slightly higher or lower depending on their buying groups.

For patients who need levothyroxine but cannot absorb standard tablets, the choice is often: pay $230 out of pocket for Tirosint, pursue insurance coverage, use the IBSA savings program, or ask a prescriber about compounded alternatives. A 2019 analysis in the Journal of the Endocrine Society found that specialty thyroid formulations impose a significant financial burden on patients who lack coverage [4]. The American Thyroid Association guidelines acknowledge that liquid levothyroxine preparations are appropriate for patients with documented absorption issues [5].

The liquid vial formulation of Tirosint (Tirosint-SOL) carries a similar list price and is available in Arizona via the same pharmacies, though it requires refrigeration after opening, which affects some patients' preference.

Does Arizona Medicaid (AHCCCS) Cover Tirosint?

Arizona Medicaid, administered by the Arizona Health Care Cost Containment System (AHCCCS), does not cover Tirosint as of 2026. AHCCCS covers generic levothyroxine tablets without prior authorization for most enrollees, but the gel capsule and liquid formulations are excluded from the AHCCCS Drug List.

This is a meaningful access barrier. Arizona had approximately 2.1 million Medicaid enrollees as of 2024 [6]. Patients with hypothyroidism who also have celiac disease, lactose intolerance, or bariatric surgery history may genuinely need an alternative formulation, but AHCCCS does not currently offer a formulary exception pathway that reliably leads to Tirosint approval.

Prescribers working with AHCCCS patients who have documented malabsorption may attempt a prior authorization, citing clinical necessity. Approvals are rare but not impossible. The more common pathway for these patients is a referral to a 503A compounding pharmacy for a compounded levothyroxine liquid or gel capsule, which is covered in the next section.

The 2023 American Association of Clinical Endocrinology (AACE) Clinical Practice Guidelines state: "Patients with gastrointestinal disorders affecting levothyroxine absorption should be considered for alternative formulations including liquid or gel capsule preparations" [7]. That guideline statement provides documentation support for a prior authorization attempt, even if AHCCCS approval rates remain low.

Is Compounded Levothyroxine Legal in Arizona?

Yes. Compounded levothyroxine in liquid or gel capsule form is legal in Arizona when prepared by a licensed 503A pharmacy operating under state board of pharmacy oversight. This is distinct from 503B outsourcing facilities, which produce sterile compounded products in bulk. For oral levothyroxine, 503A community compounding pharmacies are the appropriate channel.

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, a compounding pharmacy may prepare a levothyroxine preparation without FDA approval when a licensed prescriber provides a valid prescription for an individual patient and the preparation is not commercially available in the same strength or dose form, or when a patient has a documented medical need that the commercial product cannot meet [8]. The Arizona State Board of Pharmacy requires all 503A pharmacies to comply with USP 795 standards for non-sterile compounding.

Compounded levothyroxine is not FDA-approved and does not carry the same bioavailability data as Tirosint. The FDA's guidance on compounding and the Endocrine Society both note that compounded thyroid hormone preparations may carry batch-to-batch variability risks [9]. For patients who choose compounded levothyroxine, more frequent TSH monitoring (every 6 to 8 weeks during dose adjustment, then every 6 to 12 months when stable) is reasonable clinical practice per American Thyroid Association guidance [5].

Cost is the main reason patients and prescribers consider compounding. A compounded levothyroxine liquid or gel capsule from a licensed Arizona 503A pharmacy may cost significantly less than brand Tirosint, and some compounding pharmacies offer sliding scale or low-cost pricing for uninsured patients. The exact cost depends on the pharmacy, the dose strength, and the base used.

Which Insurance Plans Cover Tirosint in Arizona?

Coverage varies substantially by plan. Tirosint appears on some commercial insurance formularies in Arizona, typically as a non-preferred brand or specialty tier drug, which means patients pay a higher copay than for generic levothyroxine. Common structures include:

Blue Cross Blue Shield of Arizona places Tirosint on Tier 3 (non-preferred brand) for most commercial plans, with copays ranging from $50 to $90 per 30-day supply after deductible. UnitedHealthcare and Aetna plans sold in Arizona generally require a prior authorization demonstrating medical necessity before they will cover Tirosint at any tier. Cigna's Arizona formularies vary by employer group contract.

Medicare Part D plans in Arizona seldom include Tirosint on their formularies without a coverage exception request. Because Medicare Part D formulary decisions are made annually, patients should check the 2026 plan formulary directly through the Medicare Plan Finder at cms.gov.

A 2021 study in Thyroid examining access to specialty thyroid formulations found that prior authorization requirements delayed treatment initiation by a mean of 3.4 weeks for patients with documented absorption disorders [10]. That delay carries clinical risk because undertreated hypothyroidism raises LDL cholesterol, impairs cognitive function, and worsens cardiac outcomes in susceptible patients [11].

Prescribers in Arizona who want to improve approval odds should include TSH trends over time, documentation of a malabsorption diagnosis (ICD-10 K90.0 for celiac, K91.2 for postsurgical malabsorption), and a letter of medical necessity referencing AACE 2023 guidelines [7].

How Does the IBSA Savings Card Work in Arizona?

IBSA Pharma, the manufacturer of Tirosint, offers a patient savings program for commercially insured patients. Eligible patients pay as little as $25 per month for Tirosint gel capsules or Tirosint-SOL at participating pharmacies in Arizona. The savings card covers the gap between the patient's insurance copay and the $25 cap, up to a monthly maximum benefit.

Key eligibility rules: the program is open to patients with commercial (private) insurance only. Patients on Medicare, Medicaid, TRICARE, or any other government-funded program are not eligible for the IBSA savings card. Arizona AHCCCS enrollees cannot use the savings card.

Patients enroll through the IBSA website or by calling the IBSA patient services line. The card is accepted at most major retail pharmacy chains in Arizona, including CVS, Walgreens, and Fry's. Patients should confirm that their specific pharmacy participates before filling the prescription.

The savings card program does not guarantee coverage. If a patient's insurance plan requires prior authorization and the authorization is denied, the insurance portion of the payment is zero, and the savings card cannot function as designed. In that scenario, patients may end up paying the full list price minus only a small manufacturer discount. Prescribers should pursue prior authorization before assuming the savings card will resolve the cost problem.

Can I Get Tirosint Via Telehealth in Arizona?

Yes. Telehealth prescribing of Tirosint is permitted in Arizona for established patients with a documented diagnosis of hypothyroidism. Arizona enacted permanent telehealth parity legislation in 2021 (ARS 36-3606), requiring that health insurers reimburse telehealth services at parity with in-person services for covered benefits [12].

For Schedule IV controlled substances, federal law still requires an in-person visit before telehealth prescribing can begin (the DEA's 2023 telemedicine rules for controlled substances). Levothyroxine is not a controlled substance, so no in-person visit requirement applies under federal law. Arizona-licensed prescribers may evaluate a new hypothyroid patient via telehealth, review labs, and prescribe Tirosint.

Practical requirements: the patient must provide TSH and free T4 lab results (and T3 if relevant) to the telehealth provider. Most Arizona telehealth platforms accept recent labs (within 6 to 12 months) for existing hypothyroid patients and require new labs before prescribing for patients without a prior diagnosis. HealthRX providers follow the American Thyroid Association's recommendation that TSH should guide dose titration with a target TSH of 0.4 to 4.0 mIU/L for most adults, adjusted for age and clinical context [5].

After prescribing, the Tirosint prescription can be sent electronically to any retail or mail-order pharmacy in Arizona. Patients in rural Arizona, including communities in Navajo County, Apache County, and La Paz County, benefit particularly from telehealth prescribing given the limited endocrinology specialty access in those areas.

Absorption Variables That Affect Whether Tirosint Is Worth the Cost

Paying $230 per month cash, or navigating prior authorization, only makes sense if a patient has a genuine absorption problem. These are the documented conditions that reduce levothyroxine tablet absorption:

Celiac disease reduces small intestinal surface area. A 2014 study in the European Journal of Endocrinology (N=34) found that celiac patients required a mean 49% higher levothyroxine dose when taking tablet formulations compared to patients without celiac disease [13]. Switching to liquid levothyroxine in this population reduced the required dose and improved TSH stability.

Gastric acid suppression from proton pump inhibitors (PPIs) is extremely common in Arizona's older adult population, and PPIs reduce levothyroxine tablet absorption by 22 to 34% [14]. Patients on long-term PPI therapy who remain persistently hypothyroid despite escalating tablet doses are candidates for a gel capsule or liquid formulation.

Bariatric surgery, specifically Roux-en-Y gastric bypass, reduces the duodenal and jejunal surface area where levothyroxine is absorbed. Post-bariatric patients often require a 25 to 50% higher levothyroxine dose, and some do not achieve TSH control at any tablet dose [15].

Coffee, calcium, and iron supplements taken within 4 hours of levothyroxine tablets reduce absorption by 24 to 40% depending on the agent [16]. The gel capsule formulation may partially mitigate the coffee interaction specifically, though iron and calcium interference persists.

The HealthRX Tirosint Candidacy Framework (for use by Arizona prescribers):

Patients qualify for a Tirosint trial if they meet at least one of the following: (1) TSH remains above the target range on a stable, adequate tablet dose for 6 or more months with confirmed daily adherence; (2) documented diagnosis of celiac disease, inflammatory bowel disease, or short bowel syndrome; (3) active long-term PPI use with persistent hypothyroid TSH despite dose escalation; (4) post-bariatric anatomy (Roux-en-Y or sleeve gastrectomy) with ongoing TSH dysregulation; or (5) known intolerance to tablet excipients with lab-documented instability.

TSH Monitoring Timelines for Arizona Patients on Tirosint

Dose changes require time to reach steady state. Levothyroxine has a half-life of 6 to 7 days, and TSH responds to serum T4 with a lag of 4 to 6 weeks. Checking TSH sooner than 4 weeks after a dose change produces unreliable results and risks unnecessary dose adjustments [5].

For Arizona patients starting Tirosint for the first time (or switching from tablet levothyroxine), HealthRX recommends:

Check TSH 6 weeks after initiating the new formulation. If TSH is within target (0.4 to 4.0 mIU/L for most adults), recheck at 6 months. If TSH remains out of range at 6 weeks, adjust the dose by 12.5 to 25 mcg and recheck again at 6 weeks. Once stable on Tirosint for 12 months, annual TSH monitoring is appropriate for most patients. Pregnant patients require TSH monitoring every 4 weeks through 20 weeks gestation and at least once per trimester thereafter, per Endocrine Society guidelines [17].

Blood draws should be done in the morning, fasting, before the day's levothyroxine dose to ensure consistent measurement conditions. Arizona LabCorp and Quest locations are available without specialist referral for TSH, free T4, and free T3 panels.

Practical Cost-Reduction Strategies for Arizona Tirosint Patients

Patients with commercial insurance should start by requesting prior authorization with documentation of a malabsorption diagnosis or a persistent TSH elevation despite adequate tablet therapy. Approval converts an out-of-pocket cost of $230 to a copay of $25 to $90 depending on the plan tier. The IBSA savings card then reduces the remaining copay to $25 for commercially insured patients.

Patients on AHCCCS should request a referral to an Arizona 503A compounding pharmacy. The prescriber should specify the dose strength, base (glycerin-based liquid or gelatin capsule), and the absence of excipients that the patient cannot tolerate. Compounded levothyroxine is not bioequivalent to Tirosint and requires closer TSH monitoring. The Endocrine Society's 2019 position statement cautions that compounded thyroid preparations should be used only when commercial alternatives are unavailable or clinically inappropriate [9].

Mail-order pharmacy programs through 90-day supplies sometimes reduce the per-dose cost by 10 to 15% for commercially insured patients. Arizona residents with UnitedHealthcare, BCBS of Arizona, or Aetna should confirm whether their plan's mail-order benefit applies to Tirosint specifically, as formulary exceptions granted for 30-day supplies may not automatically transfer to 90-day mail-order fills.

For uninsured Arizonans with income below 250% of the federal poverty level, IBSA's patient assistance program (separate from the savings card) may provide Tirosint at no cost. Applications require income documentation and a prescriber attestation. Processing takes 4 to 6 weeks, so prescribers should initiate the application at the time of the initial prescription, not after a coverage denial.

Drug Interactions Arizona Prescribers Should Document

Several medications common in Arizona's older population interact with Tirosint and require dose or timing adjustments. Calcium carbonate taken within 4 hours of levothyroxine reduces absorption by approximately 20 to 40% [16]. Ferrous sulfate (iron supplements) similarly reduces absorption by 30 to 50% [16]. Patients taking cholestyramine, colestipol, or sevelamer must separate these drugs from levothyroxine by at least 4 to 6 hours per the FDA prescribing information [2].

Amiodarone, widely used for atrial fibrillation in Arizona's older population, interferes with T4-to-T3 conversion and can cause both hypothyroidism and hyperthyroidism. Patients on amiodarone who start Tirosint require TSH monitoring every 3 to 6 months [18]. Antiepileptic drugs including phenytoin, carbamazepine, and rifampin induce CYP450 enzymes and increase levothyroxine clearance, often requiring a 25 to 50% dose increase [2].